| Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ … P Abrams, KE Andersson, L Birder, L Brubaker, L Cardozo, C Chapple, ... Neurourol Urodyn 29 (1), 213-40, 2010 | 2146* | 2010 |
| Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience. A Wagg, G Compion, A Fahey, E Siddiqui BJU international 110 (11), 2012 | 382 | 2012 |
| 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ … P Abrams, KE Andersson, A Apostolidis, L Birder, D Bliss, L Brubaker, ... Neurourology and urodynamics 37 (7), 2271-2272, 2018 | 282 | 2018 |
| Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence CE DuBeau, GA Kuchel, T Johnson II, MH Palmer, A Wagg Neurourology and Urodynamics: Official Journal of the International …, 2010 | 236 | 2010 |
| Persistence and adherence with mirabegron versus antimuscarinic agents in patients with overactive bladder: a retrospective observational study in UK clinical practice CR Chapple, J Nazir, Z Hakimi, S Bowditch, F Fatoye, F Guelfucci, ... European urology 72 (3), 389-399, 2017 | 211 | 2017 |
| Pelvic organ prolapse and overactive bladder TA De Boer, S Salvatore, L Cardozo, C Chapple, C Kelleher, ... Neurourology and Urodynamics: Official Journal of the International …, 2010 | 209 | 2010 |
| Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus … M Oelke, K Becher, D Castro-Diaz, E Chartier-Kastler, M Kirby, A Wagg, ... Age and ageing 44 (5), 745-755, 2015 | 178 | 2015 |
| CUA guideline on adult overactive bladder J Corcos, M Przydacz, L Campeau, J Witten, D Hickling, C Honeine, ... Canadian Urological Association Journal 11 (5), E142, 2017 | 174 | 2017 |
| Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis A Wagg, JJ Wyndaele, P Sieber The American journal of geriatric pharmacotherapy 4 (1), 14-24, 2006 | 174 | 2006 |
| A review of adherence to drug therapy in patients with overactive bladder RK Basra, A Wagg, C Chapple, L Cardozo, D Castro‐Diaz, ME Pons, ... BJU international 102 (7), 774-779, 2008 | 159 | 2008 |
| Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE B Monz, E Chartier-Kastler, C Hampel, G Samsioe, S Hunskaar, ... European urology 51 (4), 1073-1082, 2007 | 159 | 2007 |
| Patient-reported impact of urinary incontinence—results from treatment seeking women in 14 European countries B Monz, ME Pons, C Hampel, S Hunskaar, D Quail, G Samsioe, D Sykes, ... Maturitas 52, 24-34, 2005 | 158 | 2005 |
| Urinary incontinence in frail elderly persons: Report from the 5th International Consultation on Incontinence A Wagg, W Gibson, J Ostaszkiewicz, T Johnson III, A Markland, ... Neurourology and urodynamics 34 (5), 398-406, 2015 | 152 | 2015 |
| Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive … A Wagg, M Dale, R Tretter, B Stow, G Compion European urology 64 (1), 74-81, 2013 | 145 | 2013 |
| Measuring resource utilization: a systematic review of validated self-reported questionnaires LE Leggett, RG Khadaroo, J Holroyd-Leduc, DL Lorenzetti, H Hanson, ... Medicine 95 (10), e2759, 2016 | 136 | 2016 |
| The efficacy and tolerability of the β3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients A Wagg, L Cardozo, VW Nitti, D Castro-Diaz, S Auerbach, MB Blauwet, ... Age and ageing 43 (5), 666-675, 2014 | 134 | 2014 |
| Flexible‐dose fesoterodine in elderly adults with overactive bladder: results of the randomized, double‐blind, placebo‐controlled study of fesoterodine in an aging population trial A Wagg, V Khullar, D Marschall‐Kehrel, MC Michel, M Oelke, A Darekar, ... Journal of the American Geriatrics Society 61 (2), 185-193, 2013 | 118 | 2013 |
| Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: early experience in Canada A Wagg, B Franks, B Ramos, T Berner Canadian Urological Association Journal 9 (9-10), 343, 2015 | 117 | 2015 |
| Can incontinence be cured? A systematic review of cure rates R Riemsma, S Hagen, R Kirschner-Hermanns, C Norton, H Wijk, ... BMC medicine 15, 1-11, 2017 | 113 | 2017 |
| Cardiovascular safety of β3-adrenoceptor agonists for the treatment of patients with overactive bladder syndrome GM Rosa, S Ferrero, VW Nitti, A Wagg, T Saleem, CR Chapple European urology 69 (2), 311-323, 2016 | 108 | 2016 |
